Over the last four years, spine M&A volume declined significantly while digital and orthobiologic assets saw increased activity.
The Numbers
The company grew 3.8% in 2024 driven by better operational performance and strategic efforts to enter higher-growth markets.
The company’s orthopedic sales grew below-market at 2% in 2024 as it worked through significant supply chain challenges.
Orthoflash®
AccuStride is designed to improve proximal phalanx and metatarsal arthroplasty outcomes, and provide custom solutions for Lapidus revision and cavus foot correction.
March 26, 2025
,
Catamaran is now indicated to treat the SI joint as either a stand-alone treatment or to augment a spinal fusion.
March 25, 2025
,
The multifilament structure is designed for cellular recruitment to promote tissue ingrowth, leading to a load-sharing construct and repair.
March 25, 2025
,
Cleared for use within levels C2 to S1, AERO can be used as a standalone facet fusion procedure or an adjunct to larger spinal fusion surgeries.
March 25, 2025
,
TrueLok Elevate provides a limb preservation treatment option for addressing bony or soft tissue deformities and defects.
March 19, 2025
,
Competitive Landscape
ORTHOWORLD Experts talk you through market forecasts, company sales and key trends.
Industry Voices
